LEGION-100: A Phase 2a Dose Escalation and Optimization trial of SYNC-T Therapy SV-102 in Patients Diagnosed With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Learn More

You can view more detailed information about the LEGION-100 trial at ClinicalTrials.gov.

To see if you qualify, please visit www.legion100trial.com or click the button to the right.